Pathophysiology in endothelin-1 transgenic mice

被引:5
|
作者
Theuring, F
Thöne-Reinecke, C
Vogler, H
Schmager, F
Rohmeiss, P
Slowinski, T
Neumayer, HH
Hocher, B
机构
[1] Humboldt Univ, Univ Clin Charite, Berlin, Germany
[2] Free Univ Berlin, Inst Pharmacol & Toxicol, D-1000 Berlin, Germany
[3] Free Univ Berlin, Dept Nephrol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Inst Mol Biol & Biochem, D-1000 Berlin, Germany
[5] Univ Heidelberg, Univ Clin Mannheim, Dept Nephrol, Heidelberg, Germany
[6] Schering Res Labs, Berlin, Germany
关键词
endothelin-1; renal hemodynamics; transgenic mouse model;
D O I
10.1097/00005344-199800001-00140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transgenic mice expressing the human endothelin-1 (ET-1) were generated. These mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. Consequently, a progressive decrease in renal blood flow and/or glomerular filtration rate was observed, demonstrated by altered creatinine clearance and by magnetic resonance imaging. These genetically altered transgenic mice provide an interesting animal model in which to elucidate the role of ET-1 in the modulation of renal hemodynamics and glomerular and tubule functions.
引用
收藏
页码:S489 / S491
页数:3
相关论文
共 50 条
  • [1] Apoptosis in kidneys of endothelin-1 transgenic mice
    Hocher, B
    Rohmeiss, P
    Thöne-Reineke, C
    Schwarz, A
    Burst, V
    van der Woude, F
    Bauer, C
    Theuring, F
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S554 - S556
  • [2] Generation and analysis of transgenic mice overexpressing endothelin-1
    Maemura, K
    Kurihara, H
    Ueda, O
    Oda, H
    Kurihara, Y
    Kuwaki, T
    Morita, H
    Kodama, T
    Suzuki, H
    Kumada, M
    Ishikawa, T
    Yazaki, Y
    CIRCULATION, 1996, 94 (08) : 3105 - 3105
  • [3] Transgenic mice that overexpress endothelin-1 develop hypertension
    Koon, MHW
    Chung, SSM
    Chung, SK
    FASEB JOURNAL, 2001, 15 (04): : A482 - A482
  • [4] Conditional cardiac overexpression of endothelin-1 in transgenic mice.
    Yang, L
    Husain, M
    Stewart, DJ
    FASEB JOURNAL, 2001, 15 (05): : A1138 - A1138
  • [5] REGULATION OF THE HUMAN ENDOTHELIN-1 GENE PROMOTER - STUDIES IN TRANSGENIC MICE
    AVERSA, CR
    WEBB, ML
    ZALAMEA, P
    SWERDEL, M
    LIRA, SA
    FASEB JOURNAL, 1994, 8 (05): : A615 - A615
  • [6] EXPRESSION OF ENDOTHELIN-1 (ET-1) REPORTER CONSTRUCTS IN TRANSGENIC MICE
    HILKERT, RJ
    LEE, ME
    BLOCH, KD
    YUN, JS
    WAGNER, TE
    QUERTERMOUS, T
    CLINICAL RESEARCH, 1991, 39 (02): : A224 - A224
  • [7] Lack of iNOS impairs endothelial function in endothelin-1 transgenic mice
    Quaschning, Thomas
    Voss, Florian
    Herzfeld, Sophia
    Relle, Katharina
    Kalk, Philipp
    Godes, Michael
    Pfab, Thiemo
    Kraemer-Guth, Annette
    Bonz, Andreas W.
    Theuring, Franz
    Galle, Jan
    Hocher, Berthold
    KIDNEY & BLOOD PRESSURE RESEARCH, 2008, 31 (02): : 127 - 134
  • [8] Angiotensin II sensitivity in afferent arterioles of endothelin-1 transgenic mice
    Bontscho, J
    Patzak, A
    Lai, EY
    Kupsch, E
    Skalweit, A
    Richter, CM
    Zimmermann, M
    Thöne-Reineke, C
    Joehren, O
    Godes, M
    Persson, P
    Hocher, B
    FASEB JOURNAL, 2005, 19 (05): : A1139 - A1139
  • [9] COMPARISON OF HEMOCONCENTRATION INDUCED BY BIG ENDOTHELIN-1 AND ENDOTHELIN-1 IN MICE
    OKUMURA, H
    ASHIZAWA, N
    KOBAYASHI, F
    ARAI, K
    ASAKURA, R
    ASHIKAWA, N
    MATSUURA, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (04) : 1395 - 1400
  • [10] Endothelin-1 Signaling in Vascular Physiology and Pathophysiology
    Sandoval, Yessica-Haydee Gomez
    Atef, Mohammed Emehdi
    Levesque, Louis-Olivier
    Li, Yuan
    Anand-Srivastava, Madhu B.
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (02) : 202 - 214